Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · HILL CITY, KS · NPI 1053632315
Verified facts
CMS Open Payments records show David Lynd Atkins, MD received $21.45 in general payments during 2025 across 1 reported records.
Viatris Specialty LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Viatris Specialty LLC | Unresolved — no canonical attribution shown | $21.45 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $21.45 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| YUPELRI Normalized: yupelri |
Drug | Viatris Specialty LLC | $21.45 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 563 | 101 |
| Levothyroxine Sodium | Levothyroxine Sodium | 428 | 67 |
| Pantoprazole Sodium | Pantoprazole Sodium | 305 | 59 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 258 | 45 |
| Lisinopril | Lisinopril | 256 | 53 |
| Potassium Chloride | Potassium Chloride | 256 | 45 |
| Furosemide | Furosemide | 253 | 38 |
| Sertraline Hcl | Sertraline Hcl | 244 | 37 |
| Amlodipine Besylate | Amlodipine Besylate | 199 | 40 |
| Eliquis | Apixaban | 178 | 28 |
| Gabapentin | Gabapentin | 178 | 30 |
| Metoprolol Succinate | Metoprolol Succinate | 173 | 31 |
| Losartan Potassium | Losartan Potassium | 164 | 36 |
| Warfarin Sodium | Warfarin Sodium | 164 | 12 |
| Meloxicam | Meloxicam | 150 | 32 |
| Tizanidine Hcl | Tizanidine Hcl | 126 | 31 |
| Omeprazole | Omeprazole | 122 | 27 |
| Tamsulosin Hcl | Tamsulosin Hcl | 122 | 19 |
| Simvastatin | Simvastatin | 113 | 25 |
| Bumetanide | Bumetanide | 106 | 13 |
| Prednisone | Prednisone | 104 | 41 |
| Levetiracetam | Levetiracetam | 99 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 96 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 94 | 16 |
| Baclofen | Baclofen | 89 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 86 | 28 |
| Metoprolol Tartrate | Metoprolol Tartrate | 84 | 19 |
| Myrbetriq | Mirabegron | 84 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 84 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 81 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 79 | 13 |
| Pregabalin | Pregabalin | 79 | 13 |
| Metformin Hcl | Metformin Hcl | 78 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 76 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 73 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 70 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 70 | 13 |
| Xarelto | Rivaroxaban | 70 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 67 | 16 |
| Allopurinol | Allopurinol | 66 | 13 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 65 | 64 |
| Finasteride | Finasteride | 65 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 65 | 13 |
| Spironolactone | Spironolactone | 65 | 13 |
| Clonazepam | Clonazepam | 64 | suppressed |
| Fentanyl | Fentanyl | 64 | suppressed |
| Carvedilol | Carvedilol | 63 | 11 |
| Ozempic | Semaglutide | 63 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 59 | suppressed |
| Atenolol | Atenolol | 58 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 57 | 15 |
| Tramadol Hcl | Tramadol Hcl | 56 | 20 |
| Famotidine | Famotidine | 53 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 52 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 51 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 50 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 50 | 13 |
| Lorazepam | Lorazepam | 50 | 14 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 50 | 13 |
| Ventolin Hfa | Albuterol Sulfate | 50 | 15 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 46 | 19 |
| Trazodone Hcl | Trazodone Hcl | 45 | suppressed |
| Memantine Hcl | Memantine Hcl | 44 | suppressed |
| Trulicity | Dulaglutide | 44 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 41 | suppressed |
| Mirtazapine | Mirtazapine | 41 | suppressed |
| Ondansetron Odt | Ondansetron | 41 | 18 |
| Fluticasone Propionate | Fluticasone Propionate | 40 | 18 |
| Jardiance | Empagliflozin | 39 | suppressed |
| Linzess | Linaclotide | 39 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 39 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 36 | suppressed |
| Digoxin | Digoxin | 36 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 34 | 11 |
| Lamotrigine | Lamotrigine | 34 | suppressed |
| Synthroid | Levothyroxine Sodium | 33 | suppressed |
| Alprazolam | Alprazolam | 32 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 32 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 32 | 17 |
| Glimepiride | Glimepiride | 31 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 31 | suppressed |
| Dutasteride | Dutasteride | 30 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 29 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 28 | 26 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 28 | 19 |
| Gemfibrozil | Gemfibrozil | 27 | suppressed |
| Levofloxacin | Levofloxacin | 27 | 23 |
| Mupirocin | Mupirocin | 27 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 26 | suppressed |
| Cefdinir | Cefdinir | 25 | 23 |
| Estradiol | Estradiol | 25 | suppressed |
| Glyburide | Glyburide | 25 | suppressed |
| Oxycontin | Oxycodone Hcl | 25 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 24 | suppressed |
| Aripiprazole | Aripiprazole | 24 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 24 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 24 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 22 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Diazepam | Diazepam | 21 | suppressed |
| Topiramate | Topiramate | 21 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 20 | 14 |
| Temazepam | Temazepam | 20 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 19 | 16 |
| Celecoxib | Celecoxib | 19 | suppressed |
| Colchicine | Colchicine | 19 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 18 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 18 | suppressed |
| Methocarbamol | Methocarbamol | 18 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Bupropion Xl | Bupropion Hcl | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 16 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 16 | suppressed |
| Nystatin | Nystatin | 16 | suppressed |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 16 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 14 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Azithromycin | Azithromycin | 14 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | suppressed |
| Ezetimibe | Ezetimibe | 14 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 13 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 13 | suppressed |
| Fetzima | Levomilnacipran Hcl | 13 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 13 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 13 | suppressed |
| Humalog | Insulin Lispro | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Olanzapine | Olanzapine | 13 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 13 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 13 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Budesonide | Budesonide | 12 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Metformin Er Gastric | Metformin Hcl | 12 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 12 | suppressed |
| Motegrity | Prucalopride Succinate | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 11 | suppressed |
| Rexulti | Brexpiprazole | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
| Striverdi Respimat | Olodaterol Hcl | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $21.45 · 1 records | Viatris Specialty LLC | YUPELRI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error